Late-Stage Active Oncology Drug Developers | An Overview
June 22, 2024
Top 15 Pharma Companies alone comprise of more than 10% of Oncology Drug Development worldwide.
Takeda Oncology (Millennium Pharmaceuticals, Inc) is a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, developing therapies for the treatment...
Takeda Oncology (Millennium Pharmaceuticals, Inc) is a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, developing therapies for the treatment...
Boehringer Ingelheim is a research-driven company operating worldwide under two divisions: Human Pharmaceuticals and Animal Healthcare. In oncology, Boehringer Ingelheim...
GlaxoSmithKline (GSK) is a global pharmaceutical company with a diversified portfolio of biologics, small molecules and consumer healthcare products. In...
GlaxoSmithKline (GSK) is a global pharmaceutical company with a diversified portfolio of biologics, small molecules and consumer healthcare products. In...
Major Oncology Approved Drugs, Drug Development Pipeline, Target Analysis, which provides you a comprehensive data and trend analysis of the...
Boehringer Ingelheim is a research-driven company operating worldwide under two divisions: Human Pharmaceuticals and Animal Healthcare. In oncology, Boehringer Ingelheim...
Oncology Drug Development Deals and Alliances Insights provides you with a comprehensive data and trend analysis of the company's Mergers...
Major Oncology Approved Drugs, Drug Development Pipeline, Target Analysis, which provides you a comprehensive data and trend analysis of the...
NK is the abbreviation of Natural Killer, and its Chinese name is natural killer cell. Due to the pan-specific...
Read moreupdated.. easy.. precise... complete...
Presenting filtered comprehensive information. Gain more insights on emerging bio-business, frame strategies, grow faster & better connect with biological science community.
LEARN MORE »
Developed by OmicsX. The entirety of this site is protected by copyright © 2010–2021 HH BioTechnologies Private Ltd.
Developed by OmicsX. The entirety of this site is protected by copyright © 2010–2021 HH BioTechnologies Private Ltd.